International Clinical Trial: A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07724366) titled 'A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis' on July 21.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Condition: Psoriasis

Intervention: Drug: TQH3906 capsules Drug: Deucravacitinib tablets 6 mg Drug: TQH3906 Capsules placebo

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enro...